FDA Peptide Reclassification 2026: What It Means for Providers The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The FDA Peptide Regulations Explained: What's Legal, What's Not, and What's Coming FDA Peptide Regulation and HHS Policy Holt Law